FDA HEIGHTENS WARNING ABOUT DIABETES DRUG DUE TO AMPUTATION RISKS
A drug that has been linked to cardiovascular injuries, strokes and kidney failure is facing even more serious scrutiny. Read More
The Food and Drug Administration (FDA) has warned that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations.